366 related articles for article (PubMed ID: 9018245)
1. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.
Loda M; Cukor B; Tam SW; Lavin P; Fiorentino M; Draetta GF; Jessup JM; Pagano M
Nat Med; 1997 Feb; 3(2):231-4. PubMed ID: 9018245
[TBL] [Abstract][Full Text] [Related]
2. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G
Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
4. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
Pagano M; Tam SW; Theodoras AM; Beer-Romero P; Del Sal G; Chau V; Yew PR; Draetta GF; Rolfe M
Science; 1995 Aug; 269(5224):682-5. PubMed ID: 7624798
[TBL] [Abstract][Full Text] [Related]
5. Absence of the cell cycle inhibitor p27Kip1 protein predicts poor outcome in patients with stage I-III colorectal cancer.
Belluco C; Esposito G; Bertorelle R; Del Mistro A; Fassina A; Vieceli G; Chieco-Bianchi L; Nitti D; Lise M
Ann Surg Oncol; 1999; 6(1):19-25. PubMed ID: 10030411
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27.
Baldassarre G; Boccia A; Bruni P; Sandomenico C; Barone MV; Pepe S; Angrisano T; Belletti B; Motti ML; Fusco A; Viglietto G
Cell Growth Differ; 2000 Oct; 11(10):517-26. PubMed ID: 11063125
[TBL] [Abstract][Full Text] [Related]
7. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
[TBL] [Abstract][Full Text] [Related]
8. Role of p27 in prostate carcinogenesis.
Macri E; Loda M
Cancer Metastasis Rev; 1998-1999; 17(4):337-44. PubMed ID: 10453277
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells.
Eguchi H; Herschenhous N; Kuzushita N; Moss SF
Cancer Res; 2003 Aug; 63(15):4739-46. PubMed ID: 12907657
[TBL] [Abstract][Full Text] [Related]
10. Kip1 degradation via the ubiquitin-proteasome pathway.
Tam SW; Theodoras AM; Pagano M
Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
[TBL] [Abstract][Full Text] [Related]
12. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
13. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M
Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210
[TBL] [Abstract][Full Text] [Related]
14. The prognostic and therapeutic relevance of p27kip1 in Ewing's family tumors.
Matsunobu T; Tanaka K; Matsumoto Y; Nakatani F; Sakimura R; Hanada M; Li X; Oda Y; Naruse I; Hoshino H; Tsuneyoshi M; Miura H; Iwamoto Y
Clin Cancer Res; 2004 Feb; 10(3):1003-12. PubMed ID: 14871979
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma.
Noguchi T; Kikuchi R; Ono K; Takeno S; Moriyama H; Uchida Y
Oncol Rep; 2003; 10(4):827-31. PubMed ID: 12792730
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
[TBL] [Abstract][Full Text] [Related]
17. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.
Wu Y; Luo H; Kanaan N; Wu J
J Cell Biochem; 2000 Jan; 76(4):596-604. PubMed ID: 10653979
[TBL] [Abstract][Full Text] [Related]
18. IFNalpha 2b induces apoptosis and proteasome-mediated degradation of p27Kip1 in a human lung cancer cell line.
Moro A; Perea SE; Pantoja C; Santos A; Araña MD; Serrano M
Oncol Rep; 2001; 8(2):425-9. PubMed ID: 11182068
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases.
Thomas GV; Szigeti K; Murphy M; Draetta G; Pagano M; Loda M
Am J Pathol; 1998 Sep; 153(3):681-7. PubMed ID: 9736017
[TBL] [Abstract][Full Text] [Related]
20. Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
Yang RM; Naitoh J; Murphy M; Wang HJ; Phillipson J; deKernion JB; Loda M; Reiter RE
J Urol; 1998 Mar; 159(3):941-5. PubMed ID: 9474188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
